Persistent Asset Partners »

Intellia Therapeutics shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $632 540 1.17

More positions owned by Persistent Asset Partners

Viking Therapeutics Call Option (VKTX)
Kodiak Sciences Call Option (KOD)
Corning Incorporated Call Option (GLW)
Eyepoint Com New Call Option (EYPT)
Corbus Pharmaceuticals Hldgs Com New Call Option (CRBP)
Capricor Therapeutics Com New Call Option (CAPR)
United Therapeutics Corporation Call Option (UTHR)
Lumentum Hldgs (LITE)
Sandisk Corp Put Option (SNDK)
Voyager Therapeutics Call Option (VYGR)
Axt (AXTI)
Vaxcyte Call Option (PCVX)
Intel Corporation (INTC)
Tower Semiconductor Shs New (TSEM)
Edgewise Therapeutics Call Option (EWTX)

View all positions for Persistent Asset Partners

Top funds holding Intellia Therapeutics

ARK Investment Management
Vanguard Group
BlackRock
State Street Corporation
Vanguard Portfolio Management
D. E. Shaw & Co
Vanguard Capital Management
Two Sigma Investments
Regeneron Pharmaceuticals
UBS Group
Geode Capital Management
Dimensional Fund Advisors
Morgan Stanley
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas

View all funds holding Intellia Therapeutics